EUVIMEDEUVIMED entdecken
Crossref

Disease‐causing STAT3 variants can be discriminated by a functional flow cytometry test

Ana Esteve-Sole, Alexandra F Freeman, Amy Hsu, Tiphanie P Vogel, Lisa Forbes Satter, Jenna R E Bergerson, Taura Webb iD, Joseph Pechacek, Kristen McDaniels, Megan A Cooper, Carolina Bouso iD, Matias Oleastro und 7 weitere

Pediatric Allergy and Immunology · 2026

DOI: 10.1111/pai.70300 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Allergy and Immunology, 2026. Verfasst von Ana Esteve-Sole und 18 weiteren Autor:innen. Beteiligte Einrichtung: Immunology Service, Department of Laboratory Medicine, NIH Clinical Center, Bethesda, Maryland, USA. Hauptthemen laut MEDLINE: STAT3 Transcription Factor, Flow Cytometry, Leukocytes, Mononuclear. Die Arbeit nennt 32 Literaturangaben. Gefördert von: NIH/NIAID, Intramural Research Program NIAID, ISCIII and EU FIS-PI21/01642.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Heterozygous STAT3 variants acting by dominant negative (DN), gain‐of‐function (GOF), or haploinsufficiency (HI) mechanisms that have been associated with different inborn errors of immunity. However, the biological impact of STAT3 variants is complex to determine and it generally involves vector‐generation, transfection, and multiple iterations for definition.

Objective

To establish a single, reliable test to functionally characterize putative disease‐causing STAT3 variants in patient primary cells.

Methods

We recruited patients carrying previously published/validated STAT3‐DN ( n = 13), STAT3‐GOF ( n = 4), and STAT3‐HI ( n = 5) variants. We functionally evaluated the IL‐10‐mediated/STAT3‐dependent inhibition ratio of LPS‐induced TNF‐α production by peripheral blood mononuclear cells (PBMC) using flow cytometry to evaluate the biologic impact of STAT3 variants. Optimization and threshold definition were performed by bootstrapping and k‐fold cross‐validation of Receiver Operating Characteristic (ROC)–area under the curve (AUC).

Results

The inhibition ratio of TNF‐α production was significantly diminished in STAT3‐DN (−3.44‐fold, p < .0001) and STAT3‐HI samples (−2.28‐fold, p < .0001), while significantly augmented in STAT3‐GOF samples (+1.47‐fold, p = .002) when compared to healthy controls (HC, n = 16). Optimizing the combinations of IL‐10 concentrations discriminated between HC and STAT3‐DN (ROC‐AUC = 1), and STAT3‐GOF (ROC‐AUC = 0.89). Further test optimization allowed discrimination between STAT3‐HI variants when compared to HC (ROC‐AUC = 1) and to STAT3‐DN (ROC‐AUC = 0.92).

Conclusion

Determination of the IL‐10 mediated, STAT3‐dependent TNFα inhibition ratio in PBMC‐derived monocytes by flow cytometry is a sensitive and specific method to functionally assess and discriminate STAT3‐DN, ‐GOF, and ‐HI variants. This test can be used in research and clinical laboratory settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

STAT3 Transcription FactorFlow CytometryLeukocytes, MononuclearHumansTumor Necrosis Factor-alphaInterleukin-10FemaleMaleChildCells, CulturedROC Curve

Stichwörter der Autor:innen

STAT3classificationclinical laboratorydiagnosis

Substanzen

STAT3 Transcription FactorSTAT3 protein, humanTumor Necrosis Factor-alphaInterleukin-10

Autor:innen und Institutionen

  • Immunology Service, Department of Laboratory Medicine, NIH Clinical Center, Bethesda, Maryland, USA.
  • Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • William T. Shearer Center for Human Immunobiology, Texas Children's Hospital, Houston, Texas, USA.
  • Department of Pediatrics, Division of Rheumatology/Immunology, Washington University in St. Louis, St. Louis, Missouri, USA.
  • Immunology Service, National Pediatric Hospital J.P. Garrahan, Buenos Aires, Argentina.
  • Immunodeficiencies Unit, Hospital 12 de Octubre, Research Institute Hospital 12 de Octubre (i+12), School of Medicine, Complutense University, Madrid, Spain.

ORCID-Profile: Taura Webb, Carolina Bouso, Sergio D Rosenzweig

Förderung

  • NIH/NIAID
  • Intramural Research Program NIAID
  • ISCIII and EU FIS-PI21/01642
  • CDI Washington University
  • Intramural Research Program NIH Clinical Center
  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Esteve-Sole, A., Freeman, A. F., Hsu, A., Vogel, T. P., Satter, L. F., Bergerson, J. R. E., Webb, T., Pechacek, J., McDaniels, K., Cooper, M. A., Bouso, C., Oleastro, M., Danielian, S., Gonzalez-Granados, L. I., Lionakis, M. S., Holland, S. M., Fleisher, T. A., Kuehn, H. S., & Rosenzweig, S. D. (2026). Disease‐causing STAT3 variants can be discriminated by a functional flow cytometry test. Pediatric Allergy and Immunology. https://doi.org/10.1111/pai.70300

Vancouver

Esteve-Sole A, Freeman AF, Hsu A, Vogel TP, Satter LF, Bergerson JRE, et al. Disease‐causing STAT3 variants can be discriminated by a functional flow cytometry test. Pediatric Allergy and Immunology. 2026. doi:10.1111/pai.70300

BibTeX
@article{EsteveSole2026,
  author = {Esteve-Sole, Ana and Freeman, Alexandra F and Hsu, Amy and Vogel, Tiphanie P and Satter, Lisa Forbes and Bergerson, Jenna R E and Webb, Taura and Pechacek, Joseph and McDaniels, Kristen and Cooper, Megan A and Bouso, Carolina and Oleastro, Matias and Danielian, Silvia and Gonzalez-Granados, Luis Ignacio and Lionakis, Michail S and Holland, Steven M and Fleisher, Thomas A and Kuehn, Hye Sun and Rosenzweig, Sergio D},
  title = {Disease‐causing STAT3 variants can be discriminated by a functional flow cytometry test},
  journal = {Pediatric Allergy and Immunology},
  year = {2026},
  doi = {10.1111/pai.70300}
}
Kostenlos starten →